Gastro-duodenal mucosal changes associated with low-dose aspirin therapy: A prospective, endoscopic study

Indian Journal of Gastroenterology

Volumn 20, Issue 6, 2001, Pages 227-229

  Chowdhury, A ^a   Ganguly, G ^a   Chowdhury, D ^a   Santra, A ^a   Gupta, J D ^a   Roy, T ^a  

^a NONE   (India)

Author keywords

Gastric adaptation; Gastro duodenal mucosal damage; Non steroidal anti inflammatory drugs

Indexed keywords

ACETYLSALICYLIC ACID; COLSPRIN; ECOSPRIN; NONSTEROID ANTIINFLAMMATORY AGENT;

ADULT; ARTICLE; BRAIN INFARCTION; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DUODENUM; ENTERIC COATED TABLET; FEMALE; FOLLOW UP; GASTROINTESTINAL ENDOSCOPY; GASTROINTESTINAL HEMORRHAGE; GASTROINTESTINAL MUCOSA; HUMAN; MALE; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; STOMACH; TRANSIENT ISCHEMIC ATTACK;

ADULT; AGED; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ASPIRIN; CEREBRAL INFARCTION; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; ENDOSCOPY, GASTROINTESTINAL; FEMALE; FOLLOW-UP STUDIES; GASTRIC MUCOSA; HUMANS; INTESTINAL MUCOSA; ISCHEMIC ATTACK, TRANSIENT; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; REFERENCE VALUES; RISK ASSESSMENT; RISK FACTORS; STATISTICS, NONPARAMETRIC; TABLETS, ENTERIC-COATED;

EID: 0035187293     PISSN: 02548860     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Nonsteroidal anti-inflammatory drugs and gastroenteropathy: Second hundred years
2. Dose effects of aspirin on gastric prostaglandins and stomach mucosal injury
3. Final report on the aspirin component of the ongoing physician's health study
4. Overt gastrointestinal bleeding in the course of chronic low-dose aspirin administration for secondary prevention of arterial occlusive disease
5. Gastrointestinal bleeding during low-dose aspirin administration for prevention of arterial occlusive events. A critical analysis
6. Prophylactic aspirin and risk of peptic ulcer bleeding
7. Risk of upper gastrointestinal bleeding associated with use of low-dose aspirin
8. Current approaches to reducing gastrointestinal toxicity of low-dose aspirin
9. Comparison of the effects of regular and enteric-coated aspirin on gastroduodenal mucosa of man
10. Endoscopic evaluation of the effects of aspirin, buffered aspirin and enteric-coated aspirin on gastric and duodenal mucosa
11. Aspirin induced gastric mucosal damage: Prevention by enteric coating and relation to prostaglandin synthesis
12. Enteric coating of aspirin significantly decreases gastroduodenal mucosal lesions
13. Protection of human gastric mucosa against aspirin - Enteric coating or dose reduction?
14. Stomach tolerance of buffered and unbuffered low-dose acetylsalicylic acid: An endoscopy controlled double-blind study in volunteers
15. Protection from gastroduodenal adverse effects of acetylsalicylic acid with ranitidine. An endoscopic controlled double-blind study of healthy subjects
16. Effects of very low dose daily, longterm aspirin therapy on gastric, duodenal and rectal prostaglandin levels and on mucosal injury in healthy humans
17. Gastro-duodenal injury associated with intake of 100-325 mg aspirin daily
18. Gastric adaptation occurs with aspirin administration in man
19. Gastric adaptation. Studies in humans during continuous aspirin administration
20. Gastric adaptation. Studies in humans during continuous aspirin administration